http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-053320-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| filingDate | 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-053320-A1 |
| titleOfInvention | TIENOISOQUINOLIN - PHENYLSULPHONAMIDS, ITS USE FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITION |
| abstract | Estrogen receptor modulators. These compounds provide a favorable means to treat the inflammatory component of certain diseases (myocardial infarction, intestinal disease and arthritis. Claim 1: A compound of formula (1) wherein R1 is hydrogen, alkyl, halogen, aryl or heteroaryl; R2, R3 , R5 and R6 are independently hydrogen, hydroxy, lower alkyl, alkoxy or halogen; R4 is alkyl; R7 is hydrogen, - (C = O) r16, -S (O) 2N (R18) (R19) or D -glucuronidate; R16 is alkyl, aralkyl or aryl; R17 is alkyl, aryl, heteroaryl, cycloalkyl, alkenyl, cycloalkenyl or alkynyl; and R18 and R19 are independently, hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, monofluoroalkyl, perfluoroalkyl aryl, arylalkyl, cycloalkenyl, heteroarylalkyl, hydroxy C2-C6 alkyl, alkoxyalkyl, alkylthioalkyl, carbonyl, acyl, alkoxycarbonyl, - (C (O) NH2, alkylaminocarbonyl, dialkylaminocarbonyl, alkylaminoalkyl or dialkylaminoalkyl; or R18 are taken together with R18 together; nitro gene to which they are attached to form a saturated, unsaturated or partially saturated C4-C6 carbon ring. |
| priorityDate | 2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.